NCCN Names Trodelvy a Preferred First-Line Treatment for Metastatic TNBCByCURE staffFebruary 4th 2026
FDA Grants Priority Review to Datroway for Metastatic Triple-Negative Breast CancerByCURE staffFebruary 3rd 2026
Breaking Down Surgical Advancements for Those With Breast CancerByDr. Kathie-Ann JosephFebruary 2nd 2026